United States · Platforms & data · GuruFocus

Journey Medical (DERM) Reports 8% Revenue Growth in Q3 2026 Amid Mixed Valuation Signals

Published by GuruFocus · United States 1 d ago

Read the full article on GuruFocus Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

Sagicor Financial declares $0.075 dividend

Insider Selling: Neuronetics (NASDAQ:STIM) Major Shareholder Sells 86,757 Shares of Company Stock

The Motley Fool

Why Liftoff Mobile Stock Soared 30% on Friday

Hours-long halt to US flights leaves travelers frustrated, anxious

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker